Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
ALI HEALTH
00241
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 5.94%76.01B | 7.60%132.66B | 3.59%71.75B | -3.15%123.29B | -4.98%69.26B | 5.08%127.29B | 5.44%72.9B | 23.97%121.14B | 48.54%69.14B | 1.77%97.72B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 86.05%-183M | 84.12%-291M | -77.54%-1.31B | -30.21%-1.83B | -53.32%-739M | 30.89%-1.41B | 66.15%-482M | -60.82%-2.04B | ---1.42B | 44.08%-1.27B |
| Interest expense - adjustment | -5.43%16.13B | 11.77%33.26B | 16.76%17.06B | -2.22%29.75B | -1.90%14.61B | -3.25%30.43B | -0.23%14.89B | 34.09%31.45B | 29.97%14.93B | -4.55%23.46B |
| Investment loss (gain) | 13.93%-15.22B | 26.72%-30.33B | 24.34%-17.69B | 4.13%-41.39B | -42.86%-23.38B | -121.30%-43.17B | -45.94%-16.36B | -45.40%-19.51B | -21.67%-11.21B | -28.09%-13.42B |
| Attributable subsidiary (profit) loss | -7.03%-4.58B | 29.49%-6.63B | 7.84%-4.28B | 15.79%-9.4B | 21.61%-4.64B | 36.42%-11.17B | 26.13%-5.92B | -21.18%-17.56B | -50.25%-8.02B | -6.90%-14.49B |
| Impairment and provisions: | -11.91%29.66B | -12.53%61.41B | -2.44%33.67B | -18.92%70.21B | -24.09%34.52B | -17.38%86.59B | -23.60%45.47B | 4.20%104.8B | 9.52%59.51B | 5.04%100.58B |
| -Other impairments and provisions | -11.91%29.66B | -12.53%61.41B | -2.44%33.67B | -18.92%70.21B | -24.09%34.52B | -17.38%86.59B | -23.60%45.47B | 4.20%104.8B | 9.52%59.51B | 5.04%100.58B |
| Revaluation surplus: | 114.58%1.47B | 109.90%565M | -12,096.43%-10.08B | -138.20%-5.71B | -42.86%84M | 6,569.70%14.95B | -34.38%147M | -118.41%-231M | -49.21%224M | 1,773.33%1.26B |
| -Fair value of investment properties (increase) | 700.00%36M | -6.78%165M | -107.14%-6M | -72.85%177M | -42.86%84M | 887.88%652M | -34.38%147M | -90.22%66M | 103.64%224M | -10.71%675M |
| -Other fair value changes | 114.23%1.43B | 106.80%400M | ---10.07B | -141.18%-5.89B | ---- | 4,912.46%14.29B | ---- | -151.21%-297M | ---- | 169.80%580M |
| Asset sale loss (gain): | ---- | -5,025.68%-3.79B | -3,038.10%-1.98B | 99.33%-74M | 99.41%-63M | -688.01%-10.98B | -2,834.81%-10.62B | 70.47%-1.39B | ---362M | -25.78%-4.72B |
| -Loss (gain) from sale of subsidiary company | ---- | -5,025.68%-3.79B | ---1.98B | 99.33%-74M | ---- | -688.01%-10.98B | -2,834.81%-10.62B | ---1.39B | ---362M | ---- |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---63M | ---- | ---- | ---- | ---- | -25.78%-4.72B |
| Depreciation and amortization: | -1.06%13.1B | 19.52%27.56B | 18.71%13.24B | 13.93%23.06B | 18.64%11.16B | -4.62%20.24B | -8.82%9.4B | 7.32%21.22B | 2.09%10.31B | -9.33%19.77B |
| -Depreciation | -1.06%13.1B | 19.52%27.56B | 18.71%13.24B | 13.93%23.06B | 18.64%11.16B | -4.62%20.24B | -8.82%9.4B | 7.32%21.22B | 2.09%10.31B | -9.33%19.77B |
| Financial expense | -17.10%5.72B | 6.00%12.9B | 21.22%6.9B | 43.67%12.17B | 44.70%5.69B | -10.19%8.47B | -17.75%3.94B | -15.40%9.43B | -22.20%4.78B | -12.23%11.15B |
| Operating profit before the change of operating capital | 13.81%122.11B | 13.61%227.31B | 0.74%107.29B | -9.57%200.08B | -6.04%106.5B | -10.54%221.25B | -17.79%113.35B | 12.40%247.31B | 26.30%137.88B | -0.31%220.03B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | -95.11%332M | 165.67%9.42B | 190.64%6.79B | -94.39%-14.35B | 51.84%-7.49B | 77.77%-7.38B | 23.83%-15.56B | -29.67%-33.21B | -304.30%-20.43B | -449.24%-25.61B |
| Accounts receivable (increase)decrease | -172.46%-103.18B | -195.12%-57B | 47.94%-37.87B | 54.30%-19.32B | 9.59%-72.74B | -750.94%-42.27B | -255.34%-80.45B | -257.98%-4.97B | -740.84%-22.64B | 105.53%3.14B |
| Accounts payable increase (decrease) | 270.24%17.26B | 49.29%-12.23B | -236.20%-10.14B | -502.45%-24.12B | -4.89%7.44B | -75.36%5.99B | 839.70%7.83B | 478.31%24.32B | 95.79%-1.06B | 124.01%4.21B |
| Financial liabilities at fair value (increase)decrease | 1,229.51%689M | 1,760.00%93M | -101.62%-61M | -99.96%5M | -78.75%3.76B | 242.78%12.7B | 288.27%17.67B | -204.33%-8.9B | -281.83%-9.39B | 3,189.13%8.53B |
| Buy and sell back financial assets (increase) decrease | -25.79%26.24B | 82.84%-15.19B | 178.03%35.36B | -214.63%-88.49B | -188.62%-45.31B | 124.30%77.2B | 99.80%51.13B | 127.77%34.42B | 181.84%25.59B | -8,237.43%-123.93B |
| Special items for working capital changes | 94.60%-20.39B | 76.22%-47.42B | -172.38%-377.59B | -6,165.52%-199.37B | -139.90%-138.63B | 98.64%-3.18B | 82.93%-57.79B | -257.53%-234.26B | -306.90%-338.47B | 84.66%148.71B |
| Borrowing from the central bank increase (decrese) | 1,267.59%7.43B | -197.33%-148.59B | -98.44%543M | 320.79%152.67B | 2,408.57%34.77B | -62.86%-69.15B | -107.98%-1.51B | -173.96%-42.46B | 115.05%18.86B | 70.04%-15.5B |
| Cash from business operations | 118.31%50.49B | -713.13%-43.61B | -146.79%-275.68B | -96.36%7.11B | -422.12%-111.7B | 1,200.24%195.16B | 116.54%34.68B | -108.08%-17.74B | -321.54%-209.64B | 19.53%219.58B |
| Other taxs | 17.26%-16.8B | 26.07%-22.11B | 1.49%-20.3B | -3.26%-29.91B | 5.79%-20.61B | -26.18%-28.97B | -28.00%-21.88B | 12.88%-22.96B | 19.28%-17.09B | -11.60%-26.35B |
| Net cash from operations | 111.38%33.69B | -188.27%-65.72B | -123.70%-295.98B | -113.72%-22.8B | -1,133.45%-132.31B | 508.40%166.19B | 105.65%12.8B | -121.06%-40.69B | -408.66%-226.73B | 20.70%193.23B |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | 92.57%3.84B | -24.56%5.6B | -28.72%1.99B | 19.12%7.42B | 21.30%2.8B | -12.30%6.23B | 11.25%2.31B | 33.59%7.1B | -15.91%2.07B | -19.60%5.32B |
| Restricted cash (increase) decrease | -111.46%-426M | ---- | 713.37%3.72B | ---- | -1,201.82%-606M | ---- | 103.28%55M | ---- | -11.07%-1.68B | ---- |
| Sale of fixed assets | 109.96%548M | -3.63%1.57B | -24.57%261M | 53.64%1.63B | -50.29%346M | -51.95%1.06B | 0.14%696M | 113.57%2.2B | 103.22%695M | -38.90%1.03B |
| Purchase of fixed assets | -166.89%-30.11B | -17.87%-28.65B | -25.53%-11.28B | -19.92%-24.3B | -89.92%-8.99B | 17.26%-20.27B | 53.13%-4.73B | -17.28%-24.49B | -28.17%-10.1B | -6.41%-20.89B |
| Sale of subsidiaries | -81.76%665M | 3,445.30%6.42B | 16,668.18%3.65B | -86.61%181M | -113.50%-22M | -36.02%1.35B | -59.85%163M | -75.44%2.11B | -92.08%406M | 254.03%8.6B |
| Acquisition of subsidiaries | -27.89%-509M | 47.11%-851M | 74.31%-398M | -101.01%-1.61B | -101.03%-1.55B | 4,828.21%158.58B | 2,017.28%150.01B | -140.09%-3.35B | -88.99%-7.82B | 80.18%-1.4B |
| Recovery of cash from investments | 77.52%3.04T | 37.57%3.86T | 29.57%1.71T | 7.74%2.81T | -2.89%1.32T | -31.22%2.61T | -33.02%1.36T | 24.50%3.79T | 58.41%2.03T | 35.91%3.04T |
| Cash on investment | -86.64%-3.15T | -39.71%-3.95T | -31.37%-1.69T | -4.61%-2.83T | 3.97%-1.29T | 33.09%-2.7T | 38.08%-1.34T | -22.77%-4.04T | -54.21%-2.16T | -30.65%-3.29T |
| Net cash from investment operations | -811.16%-141.16B | -177.36%-106.18B | -25.76%19.85B | -179.18%-38.28B | -84.21%26.74B | 117.95%48.35B | 213.94%169.39B | -5.16%-269.39B | -17.78%-148.67B | 13.61%-256.17B |
| Net cash before financing | 61.08%-107.47B | -181.43%-171.89B | -161.55%-276.13B | -128.47%-61.08B | -157.95%-105.58B | 169.19%214.54B | 148.53%182.19B | -392.65%-310.08B | -611.50%-375.4B | 53.86%-62.94B |
| Cash flow from financing activities | ||||||||||
| New borrowing | 45.16%222.93B | 7.06%309.61B | 1.73%153.58B | 68.92%289.2B | 61.12%150.96B | 1.76%171.2B | 16.17%93.7B | 38.14%168.25B | 56.92%80.65B | -4.20%121.8B |
| Refund | -13.00%-1.03T | -17.86%-1.83T | -25.51%-911.08B | -41.75%-1.55T | -39.74%-725.9B | -6.61%-1.1T | -6.95%-519.45B | -8.11%-1.03T | -33.42%-485.7B | -38.79%-951.03B |
| Issuance of bonds | -5.03%937.18B | 34.65%1.81T | 57.43%986.86B | 47.53%1.34T | 62.81%626.86B | -16.79%908.97B | -36.24%385.04B | 17.36%1.09T | 92.21%603.85B | 40.74%930.72B |
| Interest paid - financing | 8.12%-21.94B | -12.42%-49.17B | -23.73%-23.88B | -4.47%-43.74B | -13.64%-19.3B | -1.90%-41.87B | 13.13%-16.99B | -12.36%-41.08B | -4.26%-19.55B | 1.29%-36.57B |
| Dividends paid - financing | -29.81%-5.97B | -2.43%-39.87B | -227.78%-4.6B | -10.16%-38.92B | 56.17%-1.4B | -31.09%-35.33B | -129.11%-3.2B | -27.21%-26.95B | -15.54%-1.4B | -0.09%-21.19B |
| Absorb investment income | --246M | 1,237.29%3.16B | ---- | 116.51%236M | ---- | -34.73%109M | 50.00%105M | -75.15%167M | -73.58%70M | -1.03%672M |
| Issuance expenses and redemption of securities expenses | ---- | -1,037.46%-39.99B | ---- | ---3.52B | ---- | ---- | ---- | -209.11%-4B | ---- | 37.62%-1.3B |
| Other items of the financing business | -91.40%3B | 822.15%41.88B | 1,061.98%34.87B | -2.32%4.54B | -29.96%3B | -91.33%4.65B | -91.06%4.29B | 5,791.51%53.61B | 1,456.49%47.95B | -102.00%-942M |
| Net cash from financing operations | -55.65%103.23B | 1,852.78%193.82B | 638.39%232.75B | 88.21%-11.06B | 153.45%31.52B | -145.06%-93.8B | -126.44%-58.98B | 477.92%208.16B | 994.75%223.05B | -57.16%36.02B |
| Effect of rate | -221.66%-3.16B | 10.19%4.09B | -0.99%2.6B | -67.03%3.71B | -44.99%2.62B | 129.44%11.25B | 146.76%4.77B | -70.43%4.91B | 136.50%1.93B | 323.53%16.59B |
| Net Cash | 90.22%-4.24B | 130.40%21.93B | 41.42%-43.38B | -159.75%-72.14B | -160.10%-74.05B | 218.45%120.73B | 180.88%123.21B | -278.57%-101.93B | -96.09%-152.35B | 48.57%-26.92B |
| Begining period cash | 7.24%385.4B | -15.99%359.38B | -15.93%359.38B | 44.62%427.81B | 46.20%427.46B | -35.41%295.82B | -35.41%292.39B | -1.09%457.98B | -2.23%452.7B | -11.43%463.04B |
| Cash at the end | 18.65%378B | 7.24%385.4B | -10.51%318.6B | -15.99%359.38B | -15.30%356.03B | 18.52%427.81B | 39.06%420.36B | -20.27%360.95B | -20.46%302.29B | -2.23%452.7B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | KPMG | -- | KPMG | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.